BioNTech SE - ADR

NASDAQ:BNTX  
147.42
-9.11 (-5.82%)
4:50:20 PM EDT: $147.00 -0.42 (-0.29%)
Products, Community

Pfizer And Biontech Are Expected To Ask The FDA In The Coming Days To Authorize Its Booster Shot For 16- And 17-Year-Olds- Wapo

Published: 11/29/2021 22:44 GMT
BioNTech SE - ADR (BNTX) - Pfizer and Biontech Are Expected to Ask the FDA in the Coming Days to Authorize Its Booster Shot for 16- and 17-year-olds- Wapo.
((reuters.
Briefs@thomsonreuters.
Com;)).